S
SSY Group Ltd
HKEX:2005
SSY Group Ltd
HKEX:2005
Price:
2.66
HKD
-5.34%
Market Closed
Market Cap:
HK$7.7B
Relative Value
The Relative Value of one SSY Group Ltd stock under the Base Case scenario is 2.92 HKD. Compared to the current market price of 2.66 HKD, SSY Group Ltd is Undervalued by 9%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
2.92
HKD
Undervaluation 9%
S
Multiples Across Competitors
Competitors Multiples
SSY Group Ltd Competitors
SSY Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
S
|
SSY Group Ltd
HKEX:2005
|
7.9B HKD | 1.7 | 12.1 | 11.3 | 11.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
953.8B USD | 14.8 | 46.7 | 31.5 | 33.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
584.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
290.5B CHF | 4.7 | 30.9 | 13 | 15.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
245.6B CHF | 5.6 | 22.7 | 14 | 18 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.2B GBP | 5.4 | 30.8 | 17.1 | 24.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.8B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.5B USD | 2.6 | 17.4 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
